Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Pan-cancer image-based detection of clinically actionable genetic alterations
618
Zitationen
28
Autoren
2020
Jahr
Abstract
Molecular alterations in cancer can cause phenotypic changes in tumor cells and their micro-environment. Routine histopathology tissue slides - which are ubiquitously available - can reflect such morphological changes. Here, we show that deep learning can consistently infer a wide range of genetic mutations, molecular tumor subtypes, gene expression signatures and standard pathology biomarkers directly from routine histology. We developed, optimized, validated and publicly released a one-stop-shop workflow and applied it to tissue slides of more than 5000 patients across multiple solid tumors. Our findings show that a single deep learning algorithm can be trained to predict a wide range of molecular alterations from routine, paraffin-embedded histology slides stained with hematoxylin and eosin. These predictions generalize to other populations and are spatially resolved. Our method can be implemented on mobile hardware, potentially enabling point-of-care diagnostics for personalized cancer treatment. More generally, this approach could elucidate and quantify genotype-phenotype links in cancer.
Ähnliche Arbeiten
A survey on deep learning in medical image analysis
2017 · 13.833 Zit.
Dermatologist-level classification of skin cancer with deep neural networks
2017 · 13.402 Zit.
A survey on Image Data Augmentation for Deep Learning
2019 · 11.991 Zit.
QuPath: Open source software for digital pathology image analysis
2017 · 8.339 Zit.
Radiomics: Images Are More than Pictures, They Are Data
2015 · 8.105 Zit.
Autoren
- Jakob Nikolas Kather
- Lara R. Heij
- Heike I. Grabsch
- Chiara Maria Lavinia Loeffler
- Amelie Echle
- Hannah Sophie Muti
- Jeremias Krause
- Jan Niehues
- Kai Sommer
- Peter Bankhead
- Loes Kooreman
- Jefree J. Schulte
- Nicole A. Cipriani
- Roman D. Buelow
- Peter Boor
- Nadina Ortiz‐Brüchle
- Andrew M. Hanby
- Valerie Speirs
- Sara Kochanny
- Akash Patnaik
- Andrew Srisuwananukorn
- Hermann Brenner
- Michael Hoffmeister
- Piet A. van den Brandt
- Dirk Jäger
- Christian Trautwein
- Alexander T. Pearson
- Tom Luedde
Institutionen
- German Cancer Research Center(DE)
- National Center for Tumor Diseases(DE)
- Deutschen Konsortium für Translationale Krebsforschung(DE)
- RWTH Aachen University(DE)
- Maastricht University(NL)
- University of Leeds(GB)
- Maastricht University Medical Centre(NL)
- Maastro Clinic(NL)
- Institute of Genetics and Cancer(GB)
- University of Edinburgh(GB)
- University of Chicago(US)
- University of Aberdeen(GB)
- University of Illinois Chicago(US)
- Heidelberg University(DE)
- University Hospital Heidelberg(DE)
- Düsseldorf University Hospital(DE)
- Heinrich Heine University Düsseldorf(DE)